Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 241 - 250 of 1824 shown below

  • Kang, S

    J Varani, P Perone, R L Warner, M K Dame, S Kang, G J Fisher and J J Voorhees

    Vascular tube formation on matrix metalloproteinase-1-damaged collagen

    advance online publication, 2008-04-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604357

    Abstract | Full article | PDF

  • Kang, S H

    S H Kang, Y-J Bang, H-S Jong, J Y Seo, N K Kim and S-J Kim

    Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells

    doi:10.1038/sj.bjc.6690478

    Abstract | Full article | PDF

  • Kang, S-W

    I-S Park, S-W Kang, Y-J Shin, K-Y Chae, M-O Park, M-Y Kim, D N Wheatley and B-H Min

    Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth

    doi:10.1038/sj.bjc.6601181

    Abstract | Full article | PDF

  • Kang, W K

    S-H Lee, W K Kang, J Park, H Y Kim, J H Kim, S I Lee, J O Park, K Kim, C W Jung, Y S Park, Y-H Im, M H Lee and K Park

    Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

    advance online publication, 2004-06-08 00:00:00.000;

    doi:10.1038/sj.bjc.6601891

    Abstract | Full article | PDF

  • D H Lim, D Y Kim, M K Kang, Y I Kim, W K Kang, C K Park, S Kim, J H Noh, J W Joh, S H Choi, T S Sohn, J S Heo, C H Park, J O Park, J E Lee, Y J Park, H R Nam, W Park, Y C Ahn and S J Huh

    Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

    advance online publication, 2004-05-25 00:00:00.000;

    doi:10.1038/sj.bjc.6601896

    Abstract | Full article | PDF

  • S T Kim, W K Kang, J H Kang, K W Park, J Lee, S-H Lee, J O Park, K Kim, W S Kim, C W Jung, Y S Park, Y-H Im and K Park

    Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

    advance online publication, 2005-05-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602575

    Abstract | Full article | PDF

  • J-L Lee, Y-K Kang, H J Kang, K-H Lee, D Y Zang, B-Y Ryoo, J G Kim, S R Park, W K Kang, D B Shin, M-H Ryu, H M Chang, T-W Kim, J H Baek and Y J Min

    A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604536

    Abstract | Full article | PDF

  • Y H Park, M J Park, S H Ji, S Y Yi, D H Lim, D H Nam, J-I Lee, W Park, D H Choi, S J Huh, J S Ahn, W K Kang, K Park and Y-H Im

    Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

    advance online publication, 2009-02-24 00:00:00.000;

    doi:10.1038/sj.bjc.6604941

    Abstract | Full article | PDF

  • Kang, Y-K

    H J Kang, H M Chang, T W Kim, M-H Ryu, H J Sohn, J H Yook, S T Oh, B S Kim, J-S Lee and Y-K Kang

    Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

    advance online publication, 2005-01-18 00:00:00.000;

    doi:10.1038/sj.bjc.6602336

    Abstract | Full article | PDF

  • H J Kang, H M Chang, T W Kim, M-H Ryu, H-J Sohn, J H Yook, S T Oh, B S Kim, J-S Lee and Y-K Kang

    A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

    advance online publication, 2008-01-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604186

    Abstract | Full article | PDF

  • J-L Lee, Y-K Kang, H J Kang, K-H Lee, D Y Zang, B-Y Ryoo, J G Kim, S R Park, W K Kang, D B Shin, M-H Ryu, H M Chang, T-W Kim, J H Baek and Y J Min

    A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604536

    Abstract | Full article | PDF

  • Kanieff, M

    V Ascoli, G Minelli, M Kanieff, R Crialesi, L Frova and S Conti

    Cause-specific mortality in classic Kaposi's sarcoma: a population-based study in Italy (1995–2002)

    advance online publication, 2009-08-25 00:00:00.000;

    doi:10.1038/sj.bjc.6605265

    Abstract | Full article | PDF

  • Kanimozhi, V

    A Mathew, V Gajalakshmi, B Rajan, V Kanimozhi, P Brennan, B S Mathew and P Boffetta

    Anthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case–control study

    advance online publication, 2008-06-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604423

    Abstract | Full article | PDF

  • Kanis, J A

    J A Kanis, E V McCloskey, T Powles, A H G Paterson, S Ashley and T Spector

    A high incidence of vertebral fracture in women with breast cancer

    doi:10.1038/sj.bjc.6690188

    Abstract | Full article | PDF

  • Kaniwa, N

    H Ueno, K Kiyosawa and N Kaniwa

    Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

    advance online publication, 2007-06-26 00:00:00.000;

    doi:10.1038/sj.bjc.6603860

    Abstract | Full article | PDF

  • H Ueno, N Kaniwa, T Okusaka, M Ikeda, C Morizane, S Kondo, E Sugiyama, S R Kim, R Hasegawa, Y Saito, T Yoshida, N Saijo and J Sawada

    Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

    doi:10.1038/sj.bjc.6604971

    Abstract | Full article | PDF

  • Kannagi, R

    N Futamura, S Nakamura, M Tatematsu, Y Yamamura, R Kannagi and H Hirose

    Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma

    doi:10.1054/bjoc.2000.1484

    Abstract | Full article | PDF

  • K Kontani, O Taguchi, T Narita, M Izawa, N Hiraiwa, K Zenita, T Takeuchi, H Murai, S Miura and R Kannagi

    Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes

    doi:10.1054/bjoc.2000.1744

    Abstract | Full article | PDF